Roberto Sessa

Roberto Sessa is a Principal Scientist at Allogene Therapeutics, where since October 2018, responsibilities include the development of the CART process and the provision of technical expertise for optimizing CART manufacturing. Previous roles include Senior Scientist at Allogene Therapeutics focused on early process development of CAR-T cells, Scientist at Pfizer collaborating on allogenic CAR-T therapies, and Contractor Scientist at Celgene conducting in vitro assays for autoimmune disease research. Further academic experience encompasses post-doctoral positions at UC Berkeley and University California San Francisco, with significant research on lymphatic vasculature and microRNAs in vascular biology. Roberto Sessa holds a Ph.D. from the IRCC - Institute for Cancer Research and Treatment and a Master’s Degree in Industrial Biotechnology from Università degli Studi di Torino, along with a high school diploma in Chemistry.